Pfizer
S&P 500
$27.72
+0.25%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Moderate debt: debt-to-equity of 0.76.
- Net profit margin is 12.4%.
- Has paid a dividend in each of the last 5 years on record.
!Watch-points
- Return on equity is on the lower side at 9.1%.
- Return on capital employed is on the lower side at 4.6%.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreGrey zone
2.01
This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.
Piotroski F-ScoreModerate
5 / 8
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 8 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$157.99B
Current Price$ 27.72
High / Low$ 29.21 / 23.58
Stock P/E36.473682
Book Value$ 14.95
Dividend Yield6.22%
ROCE4.58%
ROE9.12%
Debt to Equity0.76
Current Ratio1.16
P/B Ratio1.8544286
EPS$ 1.36
Debt$64.64B
PAT Margin12.42%
Cash PAT$14.36B
ICR2.82